Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 3/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
| ▸ | GFER | P55789 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15255363 | 0.90 | ATM (0.35) | ATMNPSR1SMN1; SMN2MAOBCYP1A2 | |
| SCHEMBL21142321 | 0.86 | DPP4 (0.31) | — | |
| SCHEMBL2230476 | 0.81 | ELANE (0.35) | NPSR1MAOBCYP1A2CYP2A6ALDH1A1 | |
| SCHEMBL12691975 | 0.80 | MAOB (0.31) | MAOBCYP1A2CYP2A6ALDH1A1SLC6A2 | |
| SCHEMBL12691903 | 0.78 | MAOB (0.33) | MAOB | |
| SCHEMBL18643566 | 0.75 | SLC6A2 (0.36) | ATMNPSR1MAOBCYP1A2CYP2A6 | |
| SCHEMBL14578492 | 0.75 | SLC6A2 (0.36) | ATMNPSR1MAOBCYP1A2CYP2A6 | |
| SCHEMBL19367692 | 0.75 | CYP1A2 (0.33) | ATMNPSR1SMN1; SMN2MAOBCYP1A2 | |
| SCHEMBL10035307 | 0.75 | SLC6A2 (0.36) | ATMNPSR1MAOBCYP1A2CYP2A6 | |
| SCHEMBL12751334 | 0.74 | ALDH1A1 (0.33) | NPSR1SMN1; SMN2ALDH1A1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713361-B2 | Hydrogenation catalyst compositions and their use for hydrogenation of nitrile rubber | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-08-01 | — | — | US | disclosed |
| US-11673130-B2 | Catalyst system containing a metathesis catalyst and at least one phenolic compound and a process for metathesis of nitrile-butadiene rubber (NBR) using the catalyst system | ARLANXEO DEUTSCHLAND GMBH (DE) | 2023-06-13 | — | — | US | disclosed |
| US-20180223005-A1 | CATALYST COMPOSITIONS AND THEIR USE FOR HYDROGENATION OF NITRILE RUBBER | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-08-09 | — | — | US | disclosed |
| US-10011664-B2 | Functionalized nitrile rubbers and the production thereof | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-07-03 | — | — | US | disclosed |
| US-10000584-B2 | Hydrogenation of nitrile rubber | ARLANXEO DEUTSCHLAND GMBH (DE) | 2018-06-19 | — | — | US | disclosed |
| US-9920086-B2 | Ruthenium-based complexes, their preparation and use as catalysts | ARLANXEO DE GMBH (DE) | 2018-03-20 | — | — | US | disclosed |
| US-9828401-B2 | Ruthenium-based complex catalysts | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-11-28 | — | — | US | disclosed |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-11-16 | — | — | US | disclosed |
| US-9802972-B2 | Ruthenium- or osmium-based complex catalysts | ARLANXEO DEUTSCHLAND GMBH (DE) | 2017-10-31 | — | — | US | disclosed |
| US-9738671-B2 | Cyclic bent allene metal complexes | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2017-08-22 | — | — | US | disclosed |
| US-7662889-B2 | Process for the metathetic degradation of nitrile rubbers | LANXESS DEUTSCHLAND GMBH (DE) | 2010-02-16 | — | — | US | disclosed |
| US-20090076226-A1 | CATALYSTS FOR METATHESIS REACTIONS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20090076227-A1 | PROCESS FOR THE METATHETIC DEGRADATION OF NITRILE RUBBER | LANXESS DEUTSCHLAND GMBH (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20090069516-A1 | CATALYST SYSTEMS AND THEIR USE FOR METATHESIS REACTIONS | LANXESS DEUTSCHLAND GMBH (DE) | 2009-03-12 | — | — | US | disclosed |
| US-20090054597-A1 | Metathesis of Nitrile Rubbers In the Presence of Transition Metal Complex Catalysts | LANXESS DEUTSCHLAND GMBH (DE) | 2009-02-26 | — | — | US | disclosed |
| US-7470750-B2 | Method for the degradation of nitrile rubber by metathesis in the presence of ruthenium- or osmium-based catalysts | LANXESS DEUTSCHLAND GMBH (DE) | 2008-12-30 | — | — | US | disclosed |
| US-20080076881-A1 | Process for the metathetic degradation of nitrile rubbers | ARLANXEO DEUTSCHLAND GMBH (DE) | 2008-03-27 | — | — | US | disclosed |
| US-20080064822-A1 | Process for degrading nitrile rubbers in the presence of catalysts having an increased activity | ARLANXEO DEUTSCHLAND GMBH (DE) | 2008-03-13 | — | — | US | disclosed |
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | LANXESS DEUTSCHLAND GMBH (DE) | 2007-09-06 | — | — | US | disclosed |
| US-20070049700-A1 | Method for the degradation of nitrile rubber by metathesis in the presence of ruthenium- or osmium-based catalysts | LANXESS DEUTSCHLAND GMBH (DE) | 2007-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090076226-A1 | CATALYSTS FOR METATHESIS REACTIONS | MCM4, MNS1, TERT | ATM 500/4885NPSR1 2504/4885SMN1; SMN2 1266/4885 |
| US-20070208206-A1 | Novel catalyst systems and a process for reacting chemical compounds in the presence of said catalyst systems | NBAS, NNMT, CAT | ATM 399/4885NPSR1 1782/4885SMN1; SMN2 1898/4885 |
| US-20170327436-A1 | 1,3-BUTADIENE SYNTHESIS | SQLE, FDFT1, ENO1 | ATM 3963/4885NPSR1 3232/4885SMN1; SMN2 2665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.